The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses.

Cell Death and Differentiation
Tania Løve Aaes, Peter Vandenabeele

Abstract

Modern cancer therapies often involve the combination of tumor-directed cytotoxic strategies and generation of a host antitumor immune response. The latter is unleashed by immunotherapies that activate the immune system generating a more immunostimulatory tumor microenvironment and a stronger tumor antigen-specific immune response. Studying the interaction between antitumor cytotoxic therapies, dying cancer cells, and the innate and adaptive immune system requires appropriate experimental tumor models in mice. In this review, we discuss the immunostimulatory and immunosuppressive properties of cancer cell lines commonly used in immunogenic cell death (ICD) studies being apoptosis or necroptosis. We will especially focus on the antigenic component of immunogenicity. While in several cancer cell lines the epitopes of endogenously expressed tumor antigens are known, these intrinsic epitopes are rarely determined in experimental apoptotic or necroptotic ICD settings. Instead by far the most ICD research studies investigate the antigenic response against exogenously expressed model antigens such as ovalbumin or retroviral epitopes (e.g., AH1). In this review, we will argue that the immune response against endogenous tumor antigens a...Continue Reading

References

Jul 1, 1975·Journal of the National Cancer Institute·D M PurnellG L Bartlett
Feb 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J P BrownK E Hellström
Dec 1, 1975·Cancer·D P Griswold, T H Corbett
Nov 1, 1991·European Journal of Immunology·O RötzschkeH G Rammensee
Sep 1, 1987·Journal of Virology·E O Freed, R Risser
Jan 1, 1983·Annual Review of Genetics·R RisserJ McCubrey
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·A Y HuangE M Jaffee
Apr 29, 1998·Immunology and Cell Biology·R Khanna
Nov 6, 1998·The Journal of Experimental Medicine·R DyallJ Nikolić-Zugić
Nov 5, 1999·Nature Medicine·S GallucciP Matzinger
Apr 15, 2000·Cancer Gene Therapy·T A HamptonT V Strong
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G L Beatty, Y Paterson
Dec 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y ShiK L Rock
Jun 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D GolgherT Elliott
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Stephan R SchefferTim F Greten
Feb 4, 2003·Surgery·Yoshiyuki TanakaPeter S Goedegebuure
Jan 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emma Di CarloSilvano Ferrini
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wolf C BartholomaeMagdalena Tary-Lehmann
Sep 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sung-Joo ParkToshio Hirano
Dec 15, 2004·The Journal of Experimental Medicine·Gang ZhouAimee L Marson
Dec 21, 2005·The Journal of Experimental Medicine·Noelia CasaresGuido Kroemer
Feb 21, 2006·Cancer Research·Iñigo TirapuIgnacio Melero
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew G JarnickiKingston H G Mills
Jul 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Reinhold SchirmbeckJörg Reimann
Dec 26, 2006·Nature Medicine·Michel ObeidGuido Kroemer
Mar 11, 2008·Vaccine·Jennifer A McWilliamsJill E Slansky
Apr 2, 2009·European Journal of Immunology·Uta B HofmannAndreas O Eggert
Apr 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christine LohmannGeorg Häcker
Oct 14, 2009·International Journal of Immunopathology and Pharmacology·C NapoletanoM Nuti

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM-CSF

Methods Mentioned

BETA
flow cytometry
ELISA
xenografts

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis